Literature DB >> 32432133

From Characters to Time Intervals: New Paradigms for Evaluation and Neural Parsing of Time Normalizations.

Egoitz Laparra1, Dongfang Xu1, Steven Bethard1.   

Abstract

This paper presents the first model for time normalization trained on the SCATE corpus. In the SCATE schema, time expressions are annotated as a semantic composition of time entities. This novel schema favors machine learning approaches, as it can be viewed as a semantic parsing task. In this work, we propose a character level multi-output neural network that outperforms previous state-of-the-art built on the TimeML schema. To compare predictions of systems that follow both SCATE and TimeML, we present a new scoring metric for time intervals. We also apply this new metric to carry out a comparative analysis of the annotations of both schemes in the same corpus.

Entities:  

Year:  2018        PMID: 32432133      PMCID: PMC7236559          DOI: 10.1162/tacl_a_00025

Source DB:  PubMed          Journal:  Trans Assoc Comput Linguist        ISSN: 2307-387X


  2 in total

1.  Automatic identification of methotrexate-induced liver toxicity in patients with rheumatoid arthritis from the electronic medical record.

Authors:  Chen Lin; Elizabeth W Karlson; Dmitriy Dligach; Monica P Ramirez; Timothy A Miller; Huan Mo; Natalie S Braggs; Andrew Cagan; Vivian Gainer; Joshua C Denny; Guergana K Savova
Journal:  J Am Med Inform Assoc       Date:  2014-10-25       Impact factor: 4.497

2.  A synchronous context free grammar for time normalization.

Authors:  Steven Bethard
Journal:  Proc Conf Empir Methods Nat Lang Process       Date:  2013-10
  2 in total
  1 in total

1.  Time event ontology (TEO): to support semantic representation and reasoning of complex temporal relations of clinical events.

Authors:  Fang Li; Jingcheng Du; Yongqun He; Hsing-Yi Song; Mohcine Madkour; Guozheng Rao; Yang Xiang; Yi Luo; Henry W Chen; Sijia Liu; Liwei Wang; Hongfang Liu; Hua Xu; Cui Tao
Journal:  J Am Med Inform Assoc       Date:  2020-07-01       Impact factor: 4.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.